The World Health Organization (WHO) recommends the use of the integrase strand transfer inhibitor (INSTI) dolutegravir (DTG) with two nucleos (t) ide reverse transcriptase inhibitors …
The majority of people living with HIV reside in lowincome and middle-income countries (LMICs), settings in which antiretroviral HIV treatment is challenging due to scarce treatment …